These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. Hruz P; Straumann A; Bussmann C; Heer P; Simon HU; Zwahlen M; Beglinger C; Schoepfer AM; J Allergy Clin Immunol; 2011 Dec; 128(6):1349-1350.e5. PubMed ID: 22019091 [No Abstract] [Full Text] [Related]
45. Case report of proton pump inhibitor responsive esophageal eosinophilia: why 2 months of proton pump inhibitors is required. Lipka S; Muhammad A; Champeaux A; Richter JE Dis Esophagus; 2016 Aug; 29(6):700-3. PubMed ID: 24842729 [TBL] [Abstract][Full Text] [Related]
46. Diagnosis and treatment of eosinophilic esophagitis in clinical practice. Abe Y; Sasaki Y; Yagi M; Yaoita T; Nishise S; Ueno Y Clin J Gastroenterol; 2017 Apr; 10(2):87-102. PubMed ID: 28247277 [TBL] [Abstract][Full Text] [Related]
47. Transmural eosinophilic infiltration and fibrosis in a patient with non-traumatic Boerhaave's syndrome due to eosinophilic esophagitis. Fontillón M; Lucendo AJ Am J Gastroenterol; 2012 Nov; 107(11):1762. PubMed ID: 23160304 [No Abstract] [Full Text] [Related]
48. Letter: distinguishing PPI-responsive oesophageal eosinophilia from eosinophilic oesophagitis - still a long way to go. Molina-Infante J; Dellon ES; Gisbert JP Aliment Pharmacol Ther; 2014 May; 39(10):1248-9. PubMed ID: 24735150 [No Abstract] [Full Text] [Related]
49. High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia. Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Quevedo S; Bracamonte T; Román E J Pediatr Gastroenterol Nutr; 2016 May; 62(5):704-10. PubMed ID: 26513622 [TBL] [Abstract][Full Text] [Related]
50. Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis. Min SB; Nylund CM; Baker TP; Ally M; Reinhardt B; Chen YJ; Nazareno L; Moawad FJ J Clin Gastroenterol; 2017 Feb; 51(2):127-135. PubMed ID: 27479142 [TBL] [Abstract][Full Text] [Related]
52. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422 [TBL] [Abstract][Full Text] [Related]
53. Distinguishing eosinophilic esophagitis from gastroesophageal reflux disease upon PPI refractoriness: what about PPI-responsive esophageal eosinophilia? Molina-Infante J; Zamorano J Digestion; 2012; 85(3):210. PubMed ID: 22354119 [No Abstract] [Full Text] [Related]
54. Eosinophilic esophagitis in Japan: Focus on response to acid suppressive therapy. Ishimura N; Kinoshita Y J Gastroenterol Hepatol; 2018 May; 33(5):1016-1022. PubMed ID: 29278655 [TBL] [Abstract][Full Text] [Related]
55. Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences. Eluri S; Dellon ES Curr Opin Gastroenterol; 2015 Jul; 31(4):309-15. PubMed ID: 26039722 [TBL] [Abstract][Full Text] [Related]
56. A case report: asymptomatic esophageal eosinophilia after herpes simplex esophagitis. Controversies in the therapeutic approach. Iriarte Rodríguez A; Frago Marquínez I; de Lima Piña GP Rev Esp Enferm Dig; 2018 Jul; 110(7):471-472. PubMed ID: 29900745 [TBL] [Abstract][Full Text] [Related]